Revenue

The caller ID giant is expanding its ad business into Africa, MENA, and Asia, a move to diversify revenue and tap into booming mobile-first economies.

A new report reveals 67% of asset servicing errors stem from bad data. With volumes soaring, firms face a choice: comply with ISO 20022 or transform.

Faraday expands silicon-proven IP on UMC's 14nm node, targeting the booming Edge AI and IoT markets with a cost-effective, high-performance strategy.

A new global survey reveals a startling gap between knowing sleep is vital and getting quality rest. Technology tracks our every toss and turn, but is it helping?

Forget just sightseeing. A massive surge in tax-free shopping for high-tech gadgets and unique cultural goods is turning China into a global retail destination.

K2 International launches a professional indemnity unit led by 40-year veteran Richard Smart, targeting the global market from London with Lloyd's backing.

Post-listing, the Swiss HealthTech firm pushes for US market expansion and European reimbursement, streamlining its focus on AI-powered brain health.

A new four-way partnership launched at MWC promises to dismantle the barriers that have long hindered virtual mobile operators from scaling globally.

As Raya approaches, Taobao Malaysia unveils a localized campaign and hybrid retail strategy to challenge giants Shopee and Lazada in a fierce festive market.

A novel CRISPR-based therapy safely targets deadly E. coli in the gut, showing promise in the fight against antibiotic resistance and for protecting cancer patients.

Sika's new partnership with Giatec integrates AI and sensors into concrete, promising greener, cheaper, and more efficient construction projects.

Bisedge's exclusive dealership for Linde Material Handling brings advanced, green tech to East Africa, promising to boost efficiency and empower local firms.

A massive US$175M investment in EverWind is set to transform Nova Scotia into a clean energy powerhouse, with a groundbreaking Indigenous partnership at its core.

MAIA Biotechnology secured a crucial $30M to advance its promising lung cancer drug, but the move sent its stock plunging amid investor fears of dilution.

With a pivotal trial for pancreatic cancer looming, Immuneering will detail its novel 'Deep Cyclic Inhibitor' platform and strategy to investors.

NRG Energy's stock tumbles after it orchestrates a major share sale for a key investor alongside a strategic $300 million buyback, a complex move.

The AI firm reports a major financial overhaul and key acquisitions, but faces declining revenue and operational losses. Is it poised for a 2026 rebound?

With soaring revenue and new EU approval, Senseonics is taking control of its sales, but rising costs raise questions about its path to profitability.

LendingTree posts a record $319.7M Q4 driven by its insurance arm, yet an adjusted loss spooks investors. Can its AI-powered strategy win them back?

Applied Digital seeks massive debt to build a new AI factory, a high-stakes gamble in the race to power the future of artificial intelligence.